EX-99.1 2 dex991.htm PRESS RELEASE Press release

EXHIBIT 99.1

 

Jerrold J. Pellizzon

         Phil Bourdillon/Gene Heller

Chief Financial Officer

         Silverman Heller Associates

(714) 549-0421 x8262

         (310) 208-2550

jpellizzon@ceradyne.com

        

CERADYNE, INC. REPORTS 2006 FOURTH-QUARTER AND 12-MONTH RESULTS

Sales, Earnings, New Orders, and Backlog Reach Record Levels for Quarter, Year

Costa Mesa, Calif. – February 26, 2007 – Ceradyne, Inc. (Nasdaq: CRDN) (Company) today reported results for the fourth quarter and twelve months ended December 31, 2006.

Sales for the fourth quarter increased 56.6% to a record $178.7 million from $114.2 million in the fourth quarter of 2005. Net income for the fourth quarter of 2006 increased 135.1% to a record $37.7 million, or $1.38 per diluted share, compared to net income of $16.1 million, or $0.63 per diluted share, in the fourth quarter of 2005. Fully diluted average shares outstanding for the fourth quarter were 27,443,000 compared to 25,479 ,000 in the same period in 2005.

Gross profit margin increased to 40.7% of net sales in the fourth quarter of 2006 from 36.7% of net sales in the fourth quarter of 2005.

The provision for income taxes was 33.3% in the fourth quarter 2006, compared to 34.6% in the fourth quarter of 2005.

Sales for the year ended December 31, 2006, increased to a record $662.9 million, up 80.0% from $368.3 million in 2005. For the year ended December 31, 2006, net income increased to $128.4 million, or $4.69 per diluted share, on 27,352,000 average shares outstanding, from $46.8 million, or $1.86 per diluted share, on 25,107,000 average shares outstanding, for the year ended December 31, 2005. Net income for the year ended December 31, 2006 was up 174.5% over last year, and earnings per diluted share for 2006 increased 152.2% compared to 2005.

Fourth-quarter 2006 new orders were $313.5 million compared to $200.9 million in fourth-quarter 2005. For the year 2006, new orders were $730.1 million compared to $443.6 million in 2005. Total order backlog on December 31, 2006 was $344.3 million compared to the prior year backlog of $276.4 million.

Joel P. Moskowitz, Ceradyne chief executive officer, commented: “We are very pleased with our financial performance in fourth-quarter 2006 as well as the full year. The record new bookings in the fourth quarter of $313.5 million give us additional visibility into 2007.”

Moskowitz further stated, “We continue to implement our strategy of product diversification on a global scale. In the fourth quarter, we further equipped and staffed our Chicoutimi, Quebec, Canada factory for producing nuclear waste containment components combining Ceradyne’s neutron absorbing boron carbide with structural aluminum. We also began construction of our Tianjin, China factory designed to produce state-of-the-art ceramic crucibles used in the manufacturing of polycrystalline silicon for photovoltaic solar cells. We expect this new 98,000 sq. ft. plant to be in production this summer.”

-more-


Ceradyne’s management will review the financial results for the quarter and the year ended December 31, 2006 and provide an outlook on Ceradyne’s business including providing updated 2007 guidance in a conference call at 8:00 a.m. PST today. Interested parties may listen to the teleconference live via the Internet at www.ceradyne.com or www.Fulldisclosure.com. These web sites will also host an archive of the teleconference. A telephone playback will be available beginning 11:30 a.m. PST today through 9 p.m. PST on February 28, 2007. The playback can be accessed by calling 800-642-1687 (or 706-645-9291 for international callers) and providing Conference ID 9128286.

Ceradyne develops, manufactures and markets advanced technical ceramic products and components for defense, industrial, automotive/diesel and commercial applications. Additional information about the Company can be found at www.ceradyne.com.

Except for the historical information contained herein, this news release contains forward-looking statements regarding future events and the future performance of Ceradyne that involve risks and uncertainties that could cause actual results to differ materially from those projected. Words such as “anticipates,” “believes,” “plans,” “expects,” “intends,” “future,” and similar expressions are intended to identify forward-looking statements. These risks and uncertainties are described in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006, and its Quarterly Reports on Form 10-Q, as filed with the Securities and Exchange Commission.

(Financial tables next page)

 

2


Below is a summary of unaudited comparative results. Amounts in thousands except per share data.

 

     Three Months Ended
December 31,
    Year to Date as of
December 31,
 
     2006     2005     2006     2005  

Net sales

   $ 178,729     $ 114,153     $ 662,888     $ 368,253  

Cost of product sales

     106,029       72,292       401,991       237,115  
                                

Gross profit

     72,700       41,861       260,897       131,138  
                                

Operating expenses:

        

Selling

     5,551       5,385       22,919       20,694  

General and administrative

     9,176       5,835       35,293       21,014  

Research and development

     2,178       2,161       9,909       7,802  
                                
     16,905       13,381       68,121       49,510  
                                

Income from operations

     55,795       28,480       192,776       81,628  

Other income (expense):

        

Other income

     1,820       326       5,888       854  

Interest (expense)

     (1,024 )     (4,265 )     (4,105 )     (9,252 )
                                
     796       (3,939 )     1,783       (8,398 )

Income before provision for income taxes

     56,591       24,541       194,559       73,230  

Provision for income taxes

     18,851       8,487       66,155       26,452  
                                

Net income

   $ 37,740     $ 16,054     $ 128,404     $ 46,778  
                                

Earnings per share, basic

   $ 1.40     $ 0.64     $ 4.77     $ 1.90  

Earnings per share, diluted

   $ 1.38     $ 0.63     $ 4.69     $ 1.86  

Avg. shares outstanding, basic

     27,034       24,944       26,924       24,635  

Avg. shares outstanding, diluted

     27,443       25,479       27,352       25,107  

Condensed Consolidated Balance Sheets (in thousands):

 

     December 31,
2006
   December 31,
2005

Cash and cash equivalents

   $ 13,547    $ 91,542

Short term investments

     190,565    $ 7,839

Other current assets

     197,863    $ 155,836

Net property, plant and equipment

     183,011      153,259

Other assets

     28,829      21,717
             

Total assets

   $ 613,815    $ 430,193
             

Current liabilities

   $ 69,912      42,908

Long term debt

     121,000      121,000

Non current liabilities

     13,274      11,229

Deferred tax liability

     3,018      4,536

Stockholders’ equity

     406,611      250,520
             

Total liabilities and stockholders’ equity

   $ 613,815    $ 430,193
             

# # #

 

3